Salvatore Leotta

13PUBLICATIONS
54CO-AUTHORS
Epidemiological modellingApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursHaematologyPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 02, 2026
Real-World Utilization Pattern and Outcomes of Letermovir in Adult Cytomegalovirus-Seropositive Allogeneic Hematopoietic Cell Transplant Recipients: An International Retrospective Study From the Infectious Diseases Working Party of EBMT.

Jan Styczynski, Gloria Tridello, Nina Knelange

|Jul 29, 2025
Real-World Outcomes in FLT3-ITD Mutated Acute Myeloid Leukemia: Impact of NPM1 Mutations and Allogeneic Transplantation in a Retrospective Unicentric Cohort.

Veronica Vecchio, Andrea Duminuco, Salvatore Leotta

|Mar 13, 2025
No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR::ABL1 Transcript Level.

Fabio Stagno, Stefania Stella, Salvatore Leotta

|Nov 27, 2024
A New Tool Supporting the Selection of the Best Hematopoietic Stem Cell Donor by Modelling Local Own Real-World Data.

Roberto Crocchiolo, Stefania Cacace, Giuseppe Milone

|Jul 27, 2024
Early Access for Medicines in ITALY: The Case of Ruxolitinib for Patients with Graft-Versus-Host Disease.

Lucia Gozzo, Salvatore Leotta, Giovanni Luca Romano

|Nov 24, 2023
Multiple Myeloma in 2023 Ways: From Trials to Real Life.

Manlio Fazio, Vittorio Del Fabro, Nunziatina Laura Parrinello

Pageof 3

Frequent Collaborators

7 joint publications

Giuseppe Alberto Palumbo

6 joint publications

Andrea Duminuco

5 joint publications

Giuseppe Milone

4 joint publications

Uros Markovic